<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635691"><TermName>sequential AC/Taxol-Trastuzumab regimen</TermName><TermPronunciation>(see-KWEN-shul … TAK-sol-tras-TOO-zoo-mab REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen,  and AC-TH regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722831" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;sequential AC/Taxol-Trastuzumab regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722832" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen AC/Taxol-Trastuzumab en secuencia&quot;" language="es" id="_4"/><SpanishTermName>régimen AC/Taxol-Trastuzumab en secuencia</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura de una quimioterapia combinada que se usa para tratar el cáncer de mama.   Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin) y ciclofosfamida, seguidas de tratamiento con paclitaxel (Taxol) y trastuzumab (Herceptin).   También se llama AC-T-T, régimen AC-T-T,  y régimen AC-TH.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished></GlossaryTerm>
